NCT00072826View on ClinicalTrials.gov

Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 4, 2003

Primary Completion Date

August 24, 2007

Study Completion Date

August 24, 2007

Conditions
Sickle Cell Disease
Interventions
DRUG

Oxypurinol

DRUG

L-NMMA

DRUG

Acetylcholine

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00072826 - Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease | Biotech Hunter | Biotech Hunter